Valuation : H&R GmbH & Co KgaA

Market Cap 253M 294M 238M 217M 408M 27.97B 410M 2.82B 1.1B 14.18B 1.1B 1.08B 46.96B P/E 2026 *
5.27x
P/E 2027 * 18.4x
Enterprise Value 276M 321M 259M 237M 444M 30.5B 448M 3.07B 1.19B 15.47B 1.2B 1.18B 51.21B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.19x
Free-Float
21.97%
Yield 2026 *
0.74%
Yield 2027 * 0.74%
Aug. 14 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
May. 15 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
Mar. 31 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2025 CI
Jan. 28 Kepler Cheuvreux Favors BASF and Bayer, Avoids H&R and Evonik DP
Nov. 14 H&R GmbH & Co. KGaA Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
Nov. 14 H&R GmbH & Co. KGaA Revises Earnings Guidance for the Full Year 2025 CI
25-08-24 Nils Hansen acquired additional 7.78% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?15 million. CI
25-08-15 H&R GmbH & Co. KGaA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-15 Nils Hansen proposed to acquire remaining 38.55% stake in H&R GmbH & Co. KGaA from Srs Schmierstoff Vertrieb GmbH, ÖLfabrik Wilhelm Scholten GmbH, Wilhelm Scholten Beteiligungen GmbH and others for ?73 million. CI
25-05-13 H&R GmbH & Co. KGaA Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-16 H&R GmbH & Co. KGaA announces Annual dividend, payable on May 30, 2025 CI
25-04-08 H&R GmbH & Co. KGaA Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-26 H&R GmbH & Co. KGaA Says Postponement Of The Publication Of The Consolidated Financial Statements And The Annual Report 2024 RE
Manager TitleAgeSince
Chief Executive Officer 61 2015-12-31
Investor Relations Contact - 2005-12-31
Director TitleAgeSince
Chairman 62 2012-04-16
Director/Board Member 71 2011-04-30
Director/Board Member 69 2011-04-30
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 294M
-0.15%+1.10%+5.83%+22.94% 125B
+9.98%+26.30%+461.34%+259.79% 60.65B
-1.71%-1.42%-18.95%-44.82% 39.5B
-2.20%+3.16%+11.25%-18.51% 35.53B
+0.94%+2.74%+42.48%+79.00% 26.74B
+1.99%+7.85%+48.10%+21.14% 21.13B
-1.58%+2.54%+9.88%+34.10% 20.26B
+2.21%-0.18%+15.49%-34.11% 21.02B
+0.28%+1.23%+43.60%+316.88% 19.12B
Average +0.98%+6.38%+68.78%+70.71% 41.03B
Weighted average by Cap. +1.43%+6.81%+86.31%+67.15%

Financials

2026 *2027 *
Net sales 1.4B 1.62B 1.31B 1.2B 2.25B 154B 2.26B 15.53B 6.04B 78.2B 6.09B 5.95B 259B 1.36B 1.58B 1.28B 1.17B 2.19B 151B 2.21B 15.16B 5.9B 76.34B 5.94B 5.81B 253B
Net income 48.09M 55.85M 45.16M 41.22M 77.44M 5.31B 77.99M 535M 208M 2.69B 210M 205M 8.92B 13.79M 16.01M 12.95M 11.82M 22.2M 1.52B 22.36M 153M 59.69M 773M 60.13M 58.82M 2.56B
Net Debt 22.87M 26.56M 21.47M 19.6M 36.82M 2.53B 37.08M 254M 98.99M 1.28B 99.72M 97.55M 4.24B 8.65M 10.05M 8.12M 7.41M 13.93M 956M 14.03M 96.25M 37.45M 485M 37.72M 36.9M 1.61B
Logo H&R GmbH & Co KgaA
H&R GmbH & Co KGaA is a Germany-based manufacturing of chemical and pharmaceutical speciality products. The Company’s two business activities are chemicals and pharmaceutical raw materials and precision plastic parts. It operates through three segments: ChemPharm Refining, ChemPharm Sales and Plastics. The ChemPharm Refining segment, which produces oils, technical and medical white oils as well as paraffins and wax products; the ChemPharm Sales segment, which produces plasticizers and wax emulsions and the Plastics segment manufacturing precision plastic parts as well as assemblies and medical consumables.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-